China Zhong Qi Hldgs EV / EBITDA
Mi az China Zhong Qi Hldgs EV / EBITDA?
A EV / EBITDA az China Zhong Qi Hldgs Ltd. - 0.36
Mi a EV / EBITDA meghatározása?
Az EV / EBITDA a vállalati érték a kamat, az adózás, az értékcsökkenés és az amortizáció előtti eredményekkel elosztva. Ez azt jelenti, hogy mennyire drága egy állomány, és gyakrabban érvényesül a vállalatok közötti összehasonlításnál, mint az ár / nyereség arány. Megméri az árat (vállalati érték formájában), amelyet a befektető fizet a vállalat pénzforgalmának javára (EBITDA formájában).
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV / EBITDA a Materials szektor a OTC-on cégekben a China Zhong Qi Hldgs -hoz képest
Mit csinál China Zhong Qi Hldgs?
024 Pharma, Inc. provides healthcare products worldwide. Its products include vitamin and mineral supplements; stress release, joint, heart health, and weight-loss products; and skin care, hair, and anti-aging products. The company was formerly known as B Green Innovations, Inc. and changed its name to 024 Pharma, Inc. in October 2016. 024 Pharma, Inc. was incorporated in 2004 and is based in West Palm Beach, Florida.
ev / ebitda -hoz hasonló cégek China Zhong Qi Hldgs
- Aprea Therapeutics nak EV / EBITDA 0.34 van
- Sing Tao News nak EV / EBITDA 0.35 van
- Vergnet SA nak EV / EBITDA 0.35 van
- Phimedix Plc nak EV / EBITDA 0.35 van
- Boomer nak EV / EBITDA 0.35 van
- Esso nak EV / EBITDA 0.35 van
- China Zhong Qi Hldgs nak EV / EBITDA 0.36 van
- Hoth Therapeutics nak EV / EBITDA 0.36 van
- Cara Therapeutics Inc nak EV / EBITDA 0.37 van
- Kubient nak EV / EBITDA 0.37 van
- Virgin Galactic Inc nak EV / EBITDA 0.37 van
- Clover Health Investments Corp nak EV / EBITDA 0.38 van
- Ennox Ltd nak EV / EBITDA 0.38 van